Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:00 pm Purchase | 2026-03-31 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Perceptive Advisors LLC | 6,431,743 8.400% | 2,959,882![]() (+85.25%) | Filing History |
| 2026-05-15 4:00 pm Sale | 2026-03-31 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Perceptive Advisors LLC | 12,635,875 8.900% | -180,768![]() (-1.41%) | Filing History |
| 2026-05-07 4:19 pm Purchase | 2026-05-05 | 13D | LEONABIO INC LONA | Perceptive Advisors LLC | 1,882,370 19.990% | 23,048![]() (+1.24%) | Filing History |
| 2026-05-07 4:16 pm Purchase | 2026-04-30 | 13G | AVALYN PHARMA INC AVLN | Perceptive Advisors LLC | 2,675,296 6.000% | 2,675,296![]() (New Position) | Filing History |
| 2026-05-04 4:19 pm Purchase | 2026-04-30 | 13D | TRINITY BIOTECH PLC SPONSORED TRIB | Perceptive Advisors LLC | 114,133,999 9.900% | 65,365,391![]() (+134.03%) | Filing History |
| 2026-04-24 4:46 pm Purchase | 2026-04-17 | 13D | MEIRAGTX HLDGS PLC MGTX | Perceptive Advisors LLC | 11,742,117 12.600% | 1,300,555![]() (+12.46%) | Filing History |
| 2026-04-22 4:00 pm Purchase | 2026-04-15 | 13G | SPYRE THERAPEUTICS, INC SYRE | Perceptive Advisors LLC | 4,319,496 5.000% | 1,744,773![]() (+67.77%) | Filing History |
| 2026-04-21 4:19 pm Purchase | 2026-04-14 | 13G | SUTRO BIOPHARMA INC STRO | Perceptive Advisors LLC | 898,025 5.400% | 898,025![]() (New Position) | Filing History |
| 2026-04-15 4:16 pm Purchase | 2026-04-08 | 13G | ZYMEWORKS INC ZYME | Perceptive Advisors LLC | 3,974,579 5.400% | 2,899,772![]() (+269.79%) | Filing History |
| 2026-04-13 4:00 pm Sale | 2026-04-06 | 13G | KIORA PHARMACEUTICALS INC KPRX | Perceptive Advisors LLC | 438,471 9.990% | -8,966,254![]() (-95.34%) | Filing History |
| 2026-03-19 4:07 pm Purchase | 2026-03-12 | 13G | RELAY THERAPEUTICS INC RLAY | Perceptive Advisors LLC | 9,404,725 5.300% | 9,404,725![]() (New Position) | Filing History |
| 2026-03-16 4:00 pm Purchase | 2026-03-09 | 13G | EDESA BIOTECH INC EDSA | Perceptive Advisors LLC | 563,239 6.700% | 563,239![]() (New Position) | Filing History |
| 2026-03-11 4:00 pm Purchase | 2026-03-09 | 13D | SOLID BIOSCIENCES INC SLDB | Perceptive Advisors LLC | 11,969,079 12.900% | 34,400![]() (+0.29%) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | OPUS GENETICS, INC. IRD | Perceptive Advisors LLC | 7,174,154 9.990% | 2,663,653![]() (+59.05%) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Perceptive Advisors LLC | 569,308 9.100% | 130,166![]() (+29.64%) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | CELCUITY INC CELC | Perceptive Advisors LLC | 3,160,200 6.800% | 489,603![]() (+18.33%) | Filing History |
| 2026-02-17 4:00 pm Unchanged | 2025-12-31 | 13G | ADAGIO MED INC ADGM | Perceptive Advisors LLC | 15,321,655 57.500% | 0 (Unchanged) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | ALTO NEUROSCIENCE INC ANRO | Perceptive Advisors LLC | 3,249,934 9.990% | 1,260,541![]() (+63.36%) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | PALISADE BIO INC COM P PALI | Perceptive Advisors LLC | 15,200,117 9.990% | 2,957,099![]() (+24.15%) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Perceptive Advisors LLC | 12,816,643 9.990% | 6,016,699![]() (+88.48%) | Filing History |

